HIV capsid inhibitor

This page covers all HIV capsid inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting HIV capsid protein.

Targets

HIV capsid protein

Marketed (1)

• Lenacapavir long-acting · ViiV Healthcare · Infectious Disease
  Lenacapavir is a first-in-class HIV capsid inhibitor that binds to the HIV capsid protein and blocks the uncoating of viral RNA, preventing early steps of HIV replication.

Phase 3 pipeline (1)

• Lenacapavir Injection · Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida · Infectious Disease
  Lenacapavir is a first-in-class HIV capsid inhibitor that prevents the uncoating of HIV viral particles, blocking early steps of viral replication.